SCHEMBL17897759

SCHEMBL17897759

COc1ccc(-c2ccccc2)cc1NC(=S)NC(=O)c1cc(C)cc(C)c1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDPK1 O15530 1/20 0.73
▸ AKT1 P31749 1/20 0.73
▸ EPHX1 P07099 2/20 0.60
▸ ALDH1A1 P00352 7/20 0.57
▸ MAPT P10636 4/20 0.57
▸ SMN1; SMN2 Q16637 3/20 0.57
▸ ALOX12 P18054 2/20 0.57
▸ GAA P10253 2/20 0.57
▸ LMNA P02545 1/20 0.56
▸ SMO Q99835 3/20 0.55
▸ MEN1 O00255 3/20 0.54
▸ KMT2A Q03164 3/20 0.54
▸ NPC1 O15118 1/20 0.54
▸ RAB9A P51151 1/20 0.54
▸ POLB P06746 2/20 0.53
▸ HDAC1 Q13547 1/20 0.52
▸ HDAC8 Q9BY41 1/20 0.52
▸ HDAC6 Q9UBN7 1/20 0.52
▸ MIF P14174 1/20 0.50
▸ ACLY P53396 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17897757 0.90 AKT1 (0.60) PDPK1AKT1EPHX1ALDH1A1MAPT
SCHEMBL15777246 0.85 PDPK1 (0.53) PDPK1AKT1EPHX1ALDH1A1MAPT
SCHEMBL350752 0.85 AKT1 (1.00) PDPK1AKT1EPHX1ALDH1A1MAPT
SCHEMBL16119683 0.82 EPHX1 (0.81) EPHX1ALDH1A1MAPTSMN1; SMN2ALOX12
SCHEMBL15788804 0.80 AKT1 (0.73) PDPK1AKT1EPHX1ALDH1A1MAPT
SCHEMBL3047473 0.78 KMT2A (0.54) ALDH1A1MAPTSMN1; SMN2GAALMNA
SCHEMBL15778848 0.77 PDPK1 (0.73) PDPK1AKT1ALDH1A1MAPTSMN1; SMN2
SCHEMBL11161985 0.76 EPHX1 (0.70) EPHX1ALDH1A1MAPTGAALMNA
SCHEMBL3050807 0.76 KMT2A (0.55) ALDH1A1MAPTGAALMNAMEN1
SCHEMBL17897764 0.76 AKT1 (0.67) AKT1EPHX1ALDH1A1MAPTALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160194279-A1 ONE POT PROCESS FOR THE CONVERSION OF AROYL CHLORIDES TO ACYL THIOUREAS COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2016-07-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160194279-A1 ONE POT PROCESS FOR THE CONVERSION OF AROYL CHLORIDES TO ACYL THIOUREAS TRRAP, NAT1, AHR PDPK1 4430/4885AKT1 2603/4885EPHX1 2310/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback